Skip to content

Effect of Hydration Guided by Vigileo on the Prevention of CIN After PCI for Patients With AMI

Effect of Hydration Guided by Vigileo on the Prevention of Contrast Induced Nephropathy After Emergency PCI for Patients With Acute Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04382313
Enrollment
344
Registered
2020-05-11
Start date
2020-07-10
Completion date
2022-12-21
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-induced Nephropathy, Myocardial Infarction

Keywords

Hydration, Contrast-induced Nephropathy, contrast induced acute kidney injury

Brief summary

In this study, Vigileo is used to guide hydration adjustment, and SCr is used to estimate renal function. The aim of the study is to investigate the preventive effect of adequate hydration guided by Vigileo on contrast induced nephropathy in patients with acute myocardial infarction who undergo PCI.

Detailed description

This study was conducted in patients with acute myocardial infarction who undergo emergency PCI in Chinese PLA General Hospital. The patients were randomly divided into two groups: the adequate hydration group guided by Vigileo and control group. For the adequate hydration group guided by Vigileo, Vigileo equipment is used to perform hemodynamic monitoring through the femoral or radial arteries to obtain relevant hemodynamic parameters (CO, SV, SVV), and the fluid-rehydration velocity of normal saline is adjusted according to the hemodynamic parameters, and the hydration also lasts 24 hours after operation. For the control group, the routine hydration regimen is adopted, perioperative saline ≤500 ml hydration. The changes of renal function (serum creatinine, serum cystatin), symptoms and signs of cardiac insufficiency during perioperative period and cardiac objective indexes are observed. The incidence of postoperative acute pulmonary edema is recorded, and the major cardiovascular events and hemodialysis events are followed up for 6 months. By comparing the perioperative indexes of heart and kidney function between the intervention group and the control group, the preventive effect of adequate hydration guided by Vigileo on contrast induced nephropathy after PCI was clarified.

Interventions

PROCEDUREthe adequate hydration group guided by Vigileo

If the patient is mechanically ventilated, the following scheme is adopted: if SVV≤10%, then adjust the rehydration speed to 1 ml/kg/h; if 10%\<SVV\<15%, then adjust the rehydration speed to 2 ml/kg/h; if SVV≥15%, then adjust the rehydration speed to 3 ml/kg/h. The hydration lasts 24 hours after operation, and the rehydration speed is changed according to the SVV. If the patient does not use mechanical ventilation, the following scheme is adopted: 250ml normal saline is administered within 10 minutes after direct PCI, and the rehydration volume changes to 125ml in patients with mild-to-moderate congestive heart failure. If the increment of SV≥15%, then adjust the rehydration speed to 3 ml/kg/h; if 10%≤the increment of SV\<15%, then adjust the rehydration speed to 2 ml/kg/h; if the increment of SV\<10%, then adjust the rehydration speed to 1 ml/kg/h. Reassessed every 1 hour until SV is stable,and the hydration also lasts 24 hours after operation.

Sponsors

Lu jiang hospital
CollaboratorUNKNOWN
Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clearly diagnosed STEMI or NSTEMI patients: * Patients aged 18-80 years * Patients are scheduled to undergo emergency percutaneous coronary interventions * Estimated glomerular filtration rate eGFR \<120ml / min (according to MDRD formula) * Sign the informed consent to join the group.

Exclusion criteria

* Patients with mechanical complications * Patients with cardiogenic shock * Patients with aortic dissection * Patients who have malignant tumors or short-term progressive diseases that researchers believe improper to be included in the group * Hemodialysis-dependent patients with end-stage renal failure * Patients who had a history of exposure to radioactive contrast media within 1 week before or 72 hours after direct PCI * Patients who are allergic to radioactive contrast agents * Patients diagnosed with right ventricular myocardial infarction with hypotension (defined as systolic blood pressure ≤90 mmHg) on admission.

Design outcomes

Primary

MeasureTime frameDescription
Contrast induced nephropathy48-72 hours after PCIContrast induced nephropathy is defined as serum creatinine values increased by 0.5 mg/dl or 25% relative to baseline absolute values after direct PCI within 48-72 hours.

Secondary

MeasureTime frameDescription
The acute renal injury caused by contrast agent48 hours after PCIThe acute renal injury caused by contrast agent is defined as the serum creatinine value increased by 0.3 mg/dl than the baseline absolute value after direct PCI within 48 hours.
Persistent renal insufficiency3 months after PCIPersistent renal insufficiency is defined as at least 25% decrease compared with baseline in creatinine clearance 3 months after direct PCI.
renal replacement therapy and/or death from acute renal failure6 months after PCIrenal replacement therapy and/or death from acute renal failure
Major adverse cardiac events6 months after PCIall-cause death, non-lethal acute myocardial infarction, revascularization

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026